Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention Biotech Investing
Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting Biotech Investing
SkinMedica® Debuts Reimagined Packaging and Unveils New HA5® Hydra Collagen Water Burst Moisturizer Pharmaceutical Investing
Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit Medical Device Investing
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress Biotech Investing
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community Biotech Investing
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock SmartNews
